Bharat Immunological & Biologicals Corporation Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Bharat Immunological & Biologicals Corporation Ltd. on BSE

Load latest

Bharat Immunological & Biologicals Corporation Ltd.

03 Nov 2017, 11:22AM

22.94

11.47%

Result

SUBMISSION OF LIMITED REVIEW REPORT OF THE QUARTERLY UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED SEPTEMBER …

BSE India

In pursuance of Regulation 33(3) (C ) of the LODR with Stock Exchange, please find enclosed the Limited Review Report along with the financial results for the Quarter ended 30th September 2017. It is requested to kindly take the above on record please.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

26 Oct 2017

22.94

11.47%

Company Update

Updates

BSE India

Sub: Submission of Unaudited Quarterly Financial Results for the quarter ended September 2017 as Compliance of LODR 2015 Sir, In pursuance of the LODR with Stock Exchange, please find enclosed the Unaudited quarterly financial results for the quarter ended September 2017 duly approved by the Board of the Company in its Meeting on 25.10.2017. This submission of UAFR will succeeded by XBRL filing as per the requirement of Exchange. Submitted please.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

16 Oct 2017

22.94

11.47%

Company Update

Shareholding for the Period Ended September 30, 2017

BSE India

Bharat Immunologicals & Biologicals Corporation Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click here

Bharat Immunological & Biologicals Corporation Ltd.

14 Oct 2017

22.94

11.47%

Board Meeting

Board Meeting On 25 October 2017

BSE India

Bharat Immunologicals & Biologicals Corporation Limited BIBCOL CIN - L24232UP1989GOI010542 (A Govt. of India Undertaking) Regd. Office: Vill. Chola, Bulandshahr(UP)-Pin 203203 Website - www.bibcol.com Phone 09458096110 No.BIB/CS/STO.EXCHA./BM/Q2/2017-18 Dated: 14.10.2017 To, The Listing Department...

pdf

Bharat Immunological & Biologicals Corporation Ltd.

03 Oct 2017, 03:26PM

22.94

11.47%

AGM

Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

BSE India

Bharat Immunologicals & Biologicals Corporation Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here

Bharat Immunological & Biologicals Corporation Ltd.

30 Aug 2017

22.94

11.47%

AGM

Fixes Book Closure for AGM

BSE India

Bharat Immunologicals & Biologicals Corporation Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 23, 2017 to September 29, 2017 (both days inclusive) for the purpose of 28th Annual General Meeting (AGM) of the Company to be held on September 29, 2017.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

29 Aug 2017

22.94

11.47%

AGM

Intimation Of Book Closure Period From 23.09.2017 To 29.09.2017 For Twenty Eighth Annual General Meeting Scheduled …

BSE India

In compliance with the provision of LODR 2015 it is intimated that for the financial year 2016-17 the twenty eighth Annual General Meeting of the Company is Scheduled to be held on twenty ninth September 2017 Friday at 11.30 a.m. at registered office of the Company OPV Plant , Village Chola, Bulandshahr, Uttar Pradesh 203203 and the Register of Members and Share Transfer Books of the Company will remain closed from 23.09.2017 to 29.09.2017 both days inclusive.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

28 Aug 2017

22.94

11.47%

AGM

TWENTY EIGHTH ANNUAL GENERAL MEETING IS SCHEDULED TO BE HELD ON 29.09.2017 AT ITS REGISTERED OFFICE.

BSE India

In pursuance of the provision of LODR 2015 please find attached herewith the Notice of TWENTY EIGHTH Annual General Meeting of the Company on 29.09.2017 for the financial year 2016-17.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

28 Aug 2017

22.94

11.47%

AGM

TWENTY EIGHTH ANNUAL GENERAL MEETING OF THE COMPANY IS SCHEDULED TO HOLD ON 29.09.2017 AT ITS …

BSE India

In pursuance of the provision of LODR 2015 please find attached herewith the Notice of TWENTY EIGHT Annual General Meeting of the Company on 29.09.2017 for the financial year 2016-17.

pdf

Bharat Immunological & Biologicals Corporation Ltd.

08 Aug 2017

22.94

11.47%

Result

AUDITED ANNUAL ACCOUNTS FOR THE FINANCIAL YEAR 2016-17

BSE India

Sir, In pursuance of compliance of the SEBI's LODR 2015 with Stock Exchange, please find enclosed the Audited Annual Accounts for the financial year 2016-17 of the company. It is requested to kindly take the above on record please. Thanking you, Yours truly, (Sandip Kumar Lal) Company Secretary

pdf

No results found

Is Bharat Immunological & Biologicals Corporation Ltd. worth buying?

135 Votes:

Buy 69.63%

Sell 14.81%

Hold 15.56%

36.06% Fall from 52W High

High volume+gain today

Bharat Immunological & Biologicals Corporation Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Bharat Immunological & Biologicals Corporation Ltd. on BSE